The doctor of Bee Gees singer Robin Gibb hailed his “quite incredible” recovery, a day after the star woke from a coma and responded to members of his family.

It is testament to Robin’s extraordinary courage, iron will and deep reserves of physical strength that he has overcome quite incredible odds to get where he is now

Mr Gibb, 62, contracted pneumonia and fell into the coma last week.

Doctor Andrew Thillainayagam, of Imperial College Healthcare, said he had warned Robin’s wife, Dwina, son, Robin John and brother, Barry, three days ago to expect the worst.

“The prognosis was very grave, given that Robin had brain swelling from liver failure, a severe pneumonia and a weakened immune system from malnutrition,” the doctor said in a statement.

“We felt it was very likely that Robin would succumb to what seemed to be insurmountable obstacles to any form of meaningful recovery,” he added. “As a team, we were all concerned that we might be approaching the realms of futility.

“It is testament to Robin’s extraordinary courage, iron will and deep reserves of physical strength that he has overcome quite incredible odds to get where he is now.”

Mr Gibb is now fully conscious, lucid and able to speak to loved ones gathered by his hospital bed in west London.

However, Dr Thillainayagam warned that the road ahead remained uncertain but said it was “a privilege to look after such an extraordinary human being”.

Ms Gibb said that the singer’s brother, fellow Bee Gee Barry Gibb, had been singing to Robin to try to rouse him.

His three children had also been playing music to him, she said.

The Bee Gees − twins Robin and the late Maurice Gibb and their elder brother Barry, 65 − are among the biggest-selling groups of all time.

Mr Gibb had bowel surgery 18 months ago but a tumour was found and he was diagnosed with cancer of the colon and the liver.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.